Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Beyond Meat Inc. Stock Rallies 8.2%, Outperforms Market

Beyond Meat Inc. Stock Rallies 8.2%, Outperforms Market

Dow JonesDow Jones2026/08/03 20:33

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Beyond Meat Inc. advanced 8.2% to $0.61 on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 2.1% to 25,913.90 and the Dow Jones Industrial Average rising 1.3% to 53,178.41.

This was the stock's third consecutive day of gains.

Beyond Meat Inc. closed 92.0% short of its 52-week high of $7.69, which the company achieved on October 22nd.

Trading volume totaled 29.7 million, compared to the 50-day average of 31.3 million.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

August 03, 2026 16:33 ET (20:33 GMT)

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Twice thwarted in a week! Novartis (NVS.US) fails in phase III trial for blockbuster heart disease drug, stock plummets; Amgen (AMGN.US) dragged down as well

Swiss pharmaceutical giant Novartis has suffered another clinical trial setback—within one week, the company’s second major drug candidate has failed in a late-stage study. This latest disappointment concerns its potential blockbuster heart disease drug pelacarsen.

智通财经2026/09/07 07:31
Twice thwarted in a week! Novartis (NVS.US) fails in phase III trial for blockbuster heart disease drug, stock plummets; Amgen (AMGN.US) dragged down as well